Market Place
Sourcing Support
All News #Library
Biotech
Inmagene Biopharmaceuticals Completes Merger with Ikena Oncology
25 Jul 2025 //
GLOBENEWSWIRE
Ikena-Inmagene Merger Backed by ISS, Glass Lewis
11 Jul 2025 //
GLOBENEWSWIRE
Inmagene Doses First Patient in IMG-007 Phase 2b Trial
01 Jul 2025 //
GLOBENEWSWIRE
Inmagene Reports Positive Results For IMG-007 In Atopic Dermatitis
09 Jan 2025 //
GLOBENEWSWIRE
Inmagene Hosts KOL Event On OX40L Inhibition For Alopecia
09 Oct 2024 //
GLOBENEWSWIRE
Inmagene Completes Phase 2a Trial Of IMG-007 In Alopecia Areata Patients
07 May 2024 //
GLOBENEWSWIRE
Inmagene`s IMG-007 Shows Positive Interim Atopic Dermatitis Data
06 May 2024 //
GLOBENEWSWIRE
Inmagene Exercises Option to Obtain Worldwide License for IMG-007 and IMG-004
02 Feb 2024 //
PR NEWSWIRE
Inmagene Doses First Patient in Phase 2a Trial of IMG-007
13 Oct 2023 //
PR NEWSWIRE
Inmagene receives IND clearance for IMG-008, a long-acting IL-36R mAb
06 Feb 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.